pulmonary venous stenosis secondary to fibrosing mediastinitis
Conditions
Interventions
Observation Group:none
Sponsors
Beijing Chao-Yang Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years; 2. Diagnosed with fibrosing mediastinitis by CTPA; 3. Imaging confirms pulmonary vein stenosis, and a multidisciplinary team consultation evaluates the need for interventional treatment; 4. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1.Comorbid acute infection, malignancy, or active autoimmune disease; 2.Use of glucocorticoids or immunosuppressants within the past 3 months; 3.Pregnant or lactating women;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amino acids, organic acids, nucleotides, carbohydrates and other non-targeted metabolomics indicators;Target lipidomics indicators such as triacylglycerol, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, sphingomyelin, and free fatty acids; | — |
Countries
China
Contacts
Public ContactQi Yang
Beijing Chao-Yang Hospital, Capital Medical University
Outcome results
None listed